Coronavirus: Gilead to trial inhaled version of ‘appealing’ remdesivir in race for COVID-19 treatment
Gilead Sciences is to trial an inhaled version of remdesivir, a drug which it states shows guarantee in the treatment of COVID-19 The pharmaceutical business stated in an open letter that it would evaluate healthy volunteers for Stage 1 trials today, and objective to start them in August. Chairman and president Daniel O’Day stated: “If […]
The post Coronavirus: Gilead to trial inhaled version of ‘appealing’ remdesivir in race for COVID-19 treatment appeared first on World Weekly News.